Dr Gabriel Adrian a specialist in oncology based at Skåne University Comprehensive Cancer Center and Lund University in Lund, Sweden. His research interests concern clinical studies of outcome after radiotherapy, with a special interest in fractionation studies, as well as pre-clinical research in FLASH, a novel type of ultra-high dose rate irradiation with promising results for sparing normal tissue.

Dr Adrian is participant in the Swedish head & neck cancer trial group ARTSCAN. He has published in internationally recognized journals, including the International Journal of Oncology*Biology*Physics, Radiotherapy and Oncology, and others.